Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,340 | 9,180 | 3,840 | 4,840 | 5,840 |
| Receivables | 70 | 170 | 210 | 10 | 90 |
| Other current assets | 110 | 190 | 250 | 50 | 100 |
| TOTAL | $8,520 | $9,540 | $4,300 | $4,900 | $6,030 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,560 | 1,420 | 1,420 | 1,410 |
| Other Non-Current Assets | 1,580 | 1,570 | 1,620 | 1,580 | 1,620 |
| TOTAL | $1,580 | $3,130 | $3,040 | $3,000 | $3,030 |
| Total Assets | $11,100 | $12,110 | $6,820 | $7,400 | $8,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 150 | 160 | 230 | 130 | 350 |
| Accrued Expenses | 80 | 70 | 40 | 70 | 80 |
| TOTAL | $260 | $270 | $280 | $220 | $450 |
| Non-Current Liabilities | |||||
| TOTAL | $20 | $30 | $10 | $10 | $10 |
| Total Liabilities | $290 | $300 | $300 | $230 | $460 |
| Shareholders' Equity | |||||
| Common Shares | 120 | 120 | 120 | 110 | 110 |
| Retained earnings | -33,330 | -32,170 | -31,340 | -30,270 | -29,140 |
| Other shareholders' equity | 5,730 | 5,720 | -280 | -170 | -310 |
| TOTAL | $10,810 | $11,810 | $6,520 | $7,160 | $8,130 |
| Total Liabilities And Equity | $11,100 | $12,110 | $6,820 | $7,390 | $8,590 |